Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias
- PMID: 6579964
- DOI: 10.1016/0021-9150(83)90045-x
Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias
Abstract
A group of 252 chronic hemodialysis patients was examined for various risk factors. Special emphasis was placed upon the comparison of patients who had marked cardiovascular alterations with the remainder of the group. The seriousness of the risk factors was determine by hypertension and hyperlipoproteinemia, 78% of the patients received antihypertensive medication or had changes in the fundus of the eye or both. In 74% of the patients there were pathological changes in the plasma lipids or lipoproteins or both. Hypertriglyceridemia (49%) and a HDL cholesterol decrease (61%) were the most striking findings. The average VLDL cholesterol value was significantly higher and the HDL cholesterol significantly lower in the coronary heart disease group than in the remaining group. These results show that hyperlipoproteinemia and a decrease in HDL, together with other risk factors such as hypertension and anemia, play an important role in the accelerated development of atherosclerosis in a hemodialysis group.
Similar articles
-
[Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].Z Gesamte Inn Med. 1982 Dec 15;37(24):830-3. Z Gesamte Inn Med. 1982. PMID: 6963524 German. No abstract available.
-
[Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].Orv Hetil. 1986 May 11;127(19):1129-31. Orv Hetil. 1986. PMID: 3714258 Hungarian. No abstract available.
-
Serum lipids and lipoproteins in schizophrenic patients with normal renal function treated with hemodialysis.Artif Organs. 1983 Aug;7(3):353-6. doi: 10.1111/j.1525-1594.1983.tb04210.x. Artif Organs. 1983. PMID: 6578752 Clinical Trial.
-
Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.J Cardiovasc Pharmacol. 1982;4 Suppl 2:S201-5. J Cardiovasc Pharmacol. 1982. PMID: 6177957 Review. No abstract available.
-
[Dyslipoproteinemia as a coronary risk factor].Nihon Rinsho. 2003 Apr;61 Suppl 4:738-45. Nihon Rinsho. 2003. PMID: 12735059 Review. Japanese. No abstract available.
Cited by
-
Potential role of carnitine in patients with renal insufficiency.Klin Wochenschr. 1986 Jul 1;64(13):579-86. doi: 10.1007/BF01735259. Klin Wochenschr. 1986. PMID: 3091903
-
[Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].Klin Wochenschr. 1991 Aug 1;69(11):455-62. doi: 10.1007/BF01649416. Klin Wochenschr. 1991. PMID: 1921228 Review. German.
-
Changes and correlations of antioxidant enzymes, lipid peroxidation and serum neutral lipids due to haemodialysis treatment in chronic uraemic patients.Int Urol Nephrol. 1988;20(5):559-64. doi: 10.1007/BF02550619. Int Urol Nephrol. 1988. PMID: 3235307
-
The lipid story in chronic kidney disease: a long story with a happy end?Int Urol Nephrol. 2013 Oct;45(5):1273-87. doi: 10.1007/s11255-012-0296-8. Int Urol Nephrol. 2013. PMID: 23054316 Free PMC article.
-
Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease.World J Surg. 2002 Nov;26(11):1360-4. doi: 10.1007/s00268-002-6335-3. Epub 2002 Jul 22. World J Surg. 2002. PMID: 12447564
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical